BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23877620)

  • 1. Crosstalk between p38 and Smad3 through TGF-β1 in JEG-3 choriocarcinoma cells.
    Xu Q; Tan Y; Zhang K; Li Y
    Int J Oncol; 2013 Oct; 43(4):1187-93. PubMed ID: 23877620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between the p38 and TGF-β signaling pathways through TβRI, TβRII and Smad3 expression in plancental choriocarcinoma JEG-3 cells.
    Tan Y; Xu Q; Li Y; Mao X; Zhang K
    Oncol Lett; 2014 Sep; 8(3):1307-1311. PubMed ID: 25120713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
    Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
    Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease.
    Xuan YH; Choi YL; Shin YK; Ahn GH; Kim KH; Kim WJ; Lee HC; Kim SH
    Histol Histopathol; 2007 Mar; 22(3):227-34. PubMed ID: 17163397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells.
    Xu G; Chakraborty C; Lala PK
    Biochem Biophys Res Commun; 2001 Sep; 287(1):47-55. PubMed ID: 11549251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells.
    Zhang M; Fraser D; Phillips A
    Am J Pathol; 2006 Oct; 169(4):1282-93. PubMed ID: 17003485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway.
    Huang Z; Li S; Fan W; Ma Q
    Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells.
    Xu G; Chakraborty C; Lala PK
    Biochem Biophys Res Commun; 2002 Jun; 294(5):1079-86. PubMed ID: 12074587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
    Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of Smad3 restores TGF-beta response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cells.
    Xu G; Chakraborty C; Lala PK
    Biochem Biophys Res Commun; 2003 Jan; 300(2):383-90. PubMed ID: 12504095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
    Li J; Campanale NV; Liang RJ; Deane JA; Bertram JF; Ricardo SD
    Am J Pathol; 2006 Nov; 169(5):1527-40. PubMed ID: 17071578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/Smad2/3 pathway.
    Qin MY; Huang SQ; Zou XQ; Zhong XB; Yang YF; Zhang YT; Mi ZC; Zhang YS; Huang ZG
    J Ethnopharmacol; 2021 Nov; 280():114414. PubMed ID: 34314804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 Mitogen-activated protein kinase affects transforming growth factor-beta/Smad signaling in human dental pulp cells.
    Wang FM; Hu T; Tan H; Zhou XD
    Mol Cell Biochem; 2006 Oct; 291(1-2):49-54. PubMed ID: 16924420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 mitogen-activated protein kinase and alkaline phosphatase in human dental pulp cells.
    Wang FM; Hu T; Zhou X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):114-8. PubMed ID: 16831683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor-β
    Hara T; Yoshida E; Fujiwara Y; Yamamoto C; Kaji T
    J Cell Biochem; 2017 Aug; 118(8):2009-2017. PubMed ID: 28019669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.
    McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK
    Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between Smad and p38 MAPK signalling in transforming growth factor beta signal transduction in human glioblastoma cells.
    Dziembowska M; Danilkiewicz M; Wesolowska A; Zupanska A; Chouaib S; Kaminska B
    Biochem Biophys Res Commun; 2007 Mar; 354(4):1101-6. PubMed ID: 17276399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cells.
    Sullivan BP; Kassel KM; Manley S; Baker AK; Luyendyk JP
    J Pharmacol Exp Ther; 2011 May; 337(2):471-8. PubMed ID: 21303922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.